Share on LinkedInShare on LinkedIn

ARTICLE · 01 APRIL 2015

Threshold Issues: IPR Not Derailed By Unidentified D/B/A Name Or Prior ANDA Certification

Addressing threshold jurisdictional issues of a petition for inter partes review, the USPTO Patent Trial and Appeal Board determined that a d/b/a name does not create a legal entity "separate from the underlying corporate entity" that should have been named as a real party in interest.

United StatesIntellectual Property

Metrics, Inc. v. Senju Pharmaceutical Co., Ltd.

Addressing threshold jurisdictional issues of a petition for inter partes review (IPR), the U.S. Patent and Trademark Office's (USPTO) Patent Trial and Appeal Board (PTAB or Board) determined that a d/b/a name does not create a legal entity "separate from the underlying corporate entity" that should have been named as a real party in interest and that a Paragraph IV certification in an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) did not trigger a time bar to the IPR petition because the certification was not a functional equivalent to a declaratory judgment action. Metrics, Inc. v. Senju Pharmaceutical Co., Ltd., Case No. IPR2014-01041 (PTAB, Feb. 19, 2015) (Obermann, APJ.).

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from